For subscribers
S'pore company at centre of Brazil's probe into import of Indian vaccine
Madison Biotech mentioned as source of allegedly dubious invoice for advance payment
Sign up now: Get ST's newsletters delivered to your inbox
Joyce Lim Senior Business Correspondent In Singapore and Rohini Mohan India Correspondent In Bangalore, Joyce Lim, Rohini Mohan
Follow topic:
A Singapore-based company is at the centre of a Brazil government probe into alleged irregularities over the South American country's deal to purchase India's indigenous Covid-19 vaccine Covaxin.
With the world's highest death toll from Covid-19 after the United States, Brazil desperately needs vaccines, but on June 29, it cancelled its US$320 million (S$433 million) February contract with Indian vaccine maker Bharat Biotech over allegations of corruption in the deal. The company was to supply 20 million doses of Covaxin, developed with Indian government support.
